N. Picazio

Statistics

Publications

Citations

H-Index

Active since

2017

Affiliations

Apellis Pharmaceuticals (United States)(Current)

N. Picazio is an author at Apellis Pharmaceuticals (United States) specializing in non-hodgkin lymphoma therapy, lymphoma relapse, and relapsed non-hodgkin lymphoma.

Publications per year

2017–2020

Publications

INTERIM REPORT FROM A PHASE 2 MULTICENTER STUDY OF TAZEMETOSTAT, AN EZH2 INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMAS

Franck Morschhauser, Gilles Salles, Pam McKay et al. · Hematological Oncology · 2017 · 60 citations · Full text

Medicine, Oncology, Pharmacology +13

C3 Inhibition with Pegcetacoplan Targets the Underlying Disease Process of C3 Glomerulopathy (C3G) and Improves Proteinuria

Bradley P. Dixon, Larry A. Greenbaum, Liwei Huang et al. · Journal of the American Society of Nephrology · 2020 · 10 citations

Medicine, Pharmacology, Pharmacotherapy +17

1–2 of 2